covidvaccinetrial
Commenting on Pfizer’s COVID vaccine trial results and today’s trading, Gorilla Trades strategist Ken Berman said:Q3 2020 hedge fund letters, conferences and morePfizer's COVID Vaccine Trial ResultsThe major indices are mixed and flat at midday following a choppy but active morning session on Wall Street. The most COVID sensitive industries and cyclicals got another boost this morning thanks to the final results of Pfizer’s (PFE, +1.9%) vaccine trial, which showed that their candidate is even more effective than previously thought, topping Moderna’s (MRNA, -2.9%) results too. The Volatility In...
ValueWalk
Commenting on Johnson & Johnson halting its COVID vaccine trial and today’s trading Gorilla Trades strategist Ken Berman said:Q3 2020 hedge fund letters, conferences and moreJohnson & Johnson Halts COVID Vaccine TrialThe major indices are mixed and flat at midday on the heels of a choppy morning session as U.S. stocks settled down following four bullish sessions in a row. Johnson & Johnson (JNJ, -2.1%) announced that halted its promising COVID vaccine trial due to an unexplained sickness affecting one patient, which triggered a selloff in the hardest-hit industries. Global risk assets got hit ...
ValueWalk
閲覧を続けるには、ノアドット株式会社が「プライバシーポリシー」に定める「アクセスデータ」を取得することを含む「nor.利用規約」に同意する必要があります。
「これは何?」という方はこちら